Spire Wealth Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $94.3K | Buy |
|
|||||
|
2025
Q2 | $66.8K | Buy |
|
|||||
|
2025
Q1 | $55.1K | Sell |
|
|||||
|
2024
Q4 | $48.3K | Sell |
|
|||||
|
2024
Q3 | $105K | Buy |
|
|||||
|
2024
Q2 | $91.6K | Sell |
|
|||||
|
2024
Q1 | $87.1K | Buy |
|
|||||
|
2023
Q4 | $107K | Hold |
|
|||||
|
2023
Q3 | $103K | Sell |
|
|||||
|
2023
Q2 | $110K | Sell |
|
|||||
|
2023
Q1 | $179K | Buy |
|
|||||
|
2022
Q4 | $160K | Sell |
|
|||||
|
2022
Q3 | $137K | Sell |
|
|||||
|
2022
Q2 | $136K | Sell |
|
|||||
|
2022
Q1 | $221K | Buy |
|
|||||
|
2021
Q4 | $81K | Buy |
|
|||||
|
2021
Q3 | $87K | Hold |
|
|||||
|
2021
Q2 | $78K | Buy |
|
|||||
|
2021
Q1 | $62K | Buy |
|